ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FSTX F star Therapeutics Inc

7.12
0.00 (0.0%)
Nov 30 2023 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 7.20
Ask Price 7.72
News -
Day High

Low
2.99

52 Week Range

High
7.12

Day Low
Company Name Stock Ticker Symbol Market Type
F star Therapeutics Inc FSTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 7.12 19:00:00
Open Price Low Price High Price Close Price Prev Close
7.12 7.12
Trades Volume Avg Volume 52 Week Range
0 0 - 2.99 - 7.12
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 7.12 USD

F star Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 156.51M - - - -1,584.52
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

F star Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FSTX Message Board. Create One! See More Posts on FSTX Message Board See More Message Board Posts

Historical FSTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year5.607.122.995.65695,3221.5227.14%
3 Years8.7515.502.076.10248,490-1.63-18.63%
5 Years3.9015.502.076.10248,3333.2282.56%

F star Therapeutics Description

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com